Genomic sequencing and cracking the Covid code
It’s typically the case that a pharmaceutical company needs samples of a virus to create a vaccine
Edward Holmes was in Australia on a Saturday morning in early January 2020, talking on the phone with a Chinese scientist named Yong-Zhen Zhang who had just sequenced the genome of a novel pathogen that was infecting people in Wuhan.
The two men – old friends – debated the results.





